Breast cancer advocates are celebrating the funding of a live-prolonging breast cancer drug
Breast cancer advocates are celebrating the funding of a live-prolonging breast cancer drug
15 January 2020
Pharmac has struck a provisional deal for Ibrance , which costs 66-thousand a year.
Breast Cancer Aotearoa Coalition chair Libby Burgess says this is life changing for the 2000 eligible women, who won't have to fund the drug themselves any more.
© 2024 Newstalk ZB, NZCity